Microcirculatory Perfusion is Preserved during Off-Pump but not On-Pump Cardiac Surgery
This study investigated the perioperative course of microcirculatory perfusion in off-pump compared with on-pump surgery.
Necrotizing Enterocolitis in Infants With Congenital Heart Disease: The Role of Red Blood Cell Transfusions
In the preterm population, transfusion of red blood cells (RBCs) and use of RBCs with longer storage time have been independently associated with the development of NEC.
Congenital Anomalies of the Aortic Arch in Acute Type-A Aortic Dissection: Implications for Monitoring, Perfusion Strategy, and Surgical Repair
To assess whether management of acute Stanford type-A aortic dissection differs in patients with congenital anomalies of the aortic arch compared with standard institutional practice.
Effect of 6% Hydroxyethyl Starch 130/0.4 as a Priming Solution on Coagulation and Inflammation following Complex Heart Surgery
We investigated the influence of 6% hydroxyethyl starch (HES) 130/0.4 on coagulation and inflammation compared with albumin
Thromboelastography (TEG)-Based Algorithm Reduces Blood Product Utilization in Patients undergoing VAD Implant
Our results show that the strict use of a TEG-guided algorithm significantly reduces the consumption of blood products in patients undergoing VAD implant
A Need for Speed? Bypass Time and Outcomes after Isolated Aortic Valve Replacement Surgery
Despite improvements over time with regard to morbidity, mortality and long-term survival, CPB time remains a significant factor determining mediastinal blood loss, ICU and hospital length of stay, and in-hospital mortality.
The Role of Patient’s Profile and Allogeneic Blood Transfusion in Development of Post-Cardiac Surgery Infections: A Retrospective Study
Our data showed that post-cardiac surgery infections occur more frequently in patients with predetermined risk factors.
Comparison of Low Molecular Weight Hydroxyethyl Starch and Human Albumin as Priming Solutions in Children undergoing Cardiac Surgery
Human albumin is the conventional cardiopulmonary bypass circuit primer.
A factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk
Currently used anticoagulants prevent thrombosis but increase bleeding. We show an anticoagulation therapy without bleeding risk based on a plasma protease factor XII function-neutralizing antibody.